(Q50527105)

English

Albumin contamination of a purified human alpha 1-antitrypsin preparation does not affect either structural conformation or the electrophoretic mobility of the inhibitor.

scientific article published in August 1997

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/9293373

Albumin contamination of a purified human alpha 1-antitrypsin preparation does not affect either structural conformation or the electrophoretic mobility of the inhibitor. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/9293373

author name string

Finotti P

1

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/9293373

Pagetta A

2

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/9293373

publication date

1 August 1997

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/9293373

Clinica Chimica Acta

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/9293373

264

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/9293373

2

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/9293373

133-148

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/9293373

Selective removal of albumin from plasma by affinity chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900090-9

7 January 2021

Isolation and properties of human plasma α-1-proteinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900090-9

7 January 2021

Purification of alpha1-antitrypsin from plasma through thiol-disulfide interchange

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900090-9

7 January 2021

Purification of alpha-1-proteinase inhibitor. Preparation and properties of a therapeutic concentrate

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900090-9

7 January 2021

Effects of mutations in the hinge region of serpins

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900090-9

7 January 2021

Structure and variation of human alpha 1-antitrypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900090-9

7 January 2021

Alpha 1-proteinase inhibitor variant T345R. Influence of P14 residue on substrate and inhibitory pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900090-9

7 January 2021

Purification and properties of normal human alpha 1-antitrypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900090-9

7 January 2021

The preparation and properties of two new chromogenic substrates of trypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900090-9

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900090-9

7 January 2021

A genetic variant of albumin (albumin Asola; Tyr140-->Cys) with no free -SH group but with an additional disulfide bridge

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900090-9

7 January 2021

Preparation and characterization of latent alpha 1-antitrypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900090-9

7 January 2021

Effect of the Z mutation on the physical and inhibitory properties of alpha 1-antitrypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900090-9

7 January 2021

The mechanism of Z alpha 1-antitrypsin accumulation in the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900090-9

7 January 2021

Identifiers

10.1016/S0009-8981(97)00090-9

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/9293373

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/9293373

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50527105&oldid=2208891655"